| Year |
Citation |
Score |
| 2023 |
Starowicz G, Siodłak D, Nowak G, Mlyniec K. The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission. Pharmacological Reports : Pr. 75: 609-622. PMID 36997827 DOI: 10.1007/s43440-023-00478-0 |
0.309 |
|
| 2022 |
Rafało-Ulińska A, Pochwat B, Misztak P, Bugno R, Kryczyk-Poprawa A, Opoka W, Muszyńska B, Poleszak E, Nowak G, Szewczyk B. Zinc Deficiency Blunts the Effectiveness of Antidepressants in the Olfactory Bulbectomy Model of Depression in Rats. Nutrients. 14. PMID 35807926 DOI: 10.3390/nu14132746 |
0.323 |
|
| 2021 |
Mlyniec K, Siodłak D, Doboszewska U, Nowak G. GPCR oligomerization as a target for antidepressants: Focus on GPR39. Pharmacology & Therapeutics. 107842. PMID 33746052 DOI: 10.1016/j.pharmthera.2021.107842 |
0.324 |
|
| 2021 |
Siodłak D, Nowak G, Mlyniec K. Interaction between zinc, the GPR39 zinc receptor and the serotonergic system in depression. Brain Research Bulletin. PMID 33549699 DOI: 10.1016/j.brainresbull.2021.02.003 |
0.33 |
|
| 2021 |
Misztak P, Sowa-Kućma M, Szewczyk B, Nowak G. Vorinostat (SAHA) May Exert Its Antidepressant-Like Effects Through the Modulation of Oxidative Stress Pathways. Neurotoxicity Research. PMID 33400178 DOI: 10.1007/s12640-020-00317-7 |
0.301 |
|
| 2020 |
Rafało-Ulińska A, Poleszak E, Szopa A, Serefko A, Rogowska M, Sowa I, Wójciak M, Muszyńska B, Krakowska A, Gdula-Argasińska J, Kała K, Jasiewicz B, Opoka W, Szewczyk B, Nowak G. Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action. Nutrients. 12. PMID 32825449 DOI: 10.3390/Nu12092529 |
0.359 |
|
| 2020 |
Pochwat B, Domin H, Rafało-Ulińska A, Szewczyk B, Nowak G. Ketamine and Ro 25-6981 Reverse Behavioral Abnormalities in Rats Subjected to Dietary Zinc Restriction. International Journal of Molecular Sciences. 21. PMID 32640759 DOI: 10.3390/Ijms21134791 |
0.481 |
|
| 2020 |
Wróbel MZ, Chodkowski A, Marciniak M, Dawidowski M, Maksymiuk A, Siwek A, Nowak G, Turło J. Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT and D receptor affinity and serotonin transporter inhibition. Bioorganic Chemistry. 97: 103662. PMID 32086055 DOI: 10.1016/J.Bioorg.2020.103662 |
0.348 |
|
| 2019 |
Piotrowska A, Siwek A, Wolak M, Nowak G. Analysis of Density Changes of Selected Brain Receptors After a 14-Day Supply of Chromium(III) and Evaluation of Chromium(III) Affinity to Selected Receptors and Transporters. Biological Trace Element Research. PMID 31732929 DOI: 10.1007/S12011-019-01924-Y |
0.392 |
|
| 2019 |
Wróbel MZ, Chodkowski A, Herold F, Marciniak M, Dawidowski M, Siwek A, Starowicz G, Stachowicz K, Szewczyk B, Nowak G, Belka M, Bączek T, Satała G, Bojarski AJ, Turło J. Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect. European Journal of Medicinal Chemistry. 183: 111736. PMID 31586817 DOI: 10.1016/J.Ejmech.2019.111736 |
0.324 |
|
| 2019 |
Pochwat B, Nowak G, Szewczyk B. An update on NMDA antagonists in depression. Expert Review of Neurotherapeutics. 1-13. PMID 31328587 DOI: 10.1080/14737175.2019.1643237 |
0.456 |
|
| 2019 |
Ślifirski G, Król M, Kleps J, Podsadni P, Belka M, Bączek T, Siwek A, Stachowicz K, Szewczyk B, Nowak G, Bojarski A, Kozioł AE, Turło J, Herold F. Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT receptor ligands. European Journal of Medicinal Chemistry. 180: 383-397. PMID 31325785 DOI: 10.1016/J.Ejmech.2019.07.027 |
0.313 |
|
| 2019 |
Zeitler S, Ye L, Andreyeva A, Schumacher F, Monti J, Nürnberg B, Nowak G, Kleuser B, Reichel M, Fejtová A, Kornhuber J, Rhein C, Friedland K. Acid Sphingomyelinase - a Regulator of TRPC6 Channel Activity. Journal of Neurochemistry. PMID 31310676 DOI: 10.1111/Jnc.14823 |
0.317 |
|
| 2019 |
Szewczyk B, Pochwat B, Muszyńska B, Opoka W, Krakowska A, Rafało-Ulińska A, Friedland K, Nowak G. Antidepressant-like activity of hyperforin and changes in BDNF and zinc levels in mice exposed to chronic unpredictable mild stress. Behavioural Brain Research. 372: 112045. PMID 31220487 DOI: 10.1016/J.Bbr.2019.112045 |
0.431 |
|
| 2019 |
Ślifirski G, Król M, Kleps J, Ulenberg S, Belka M, Bączek T, Siwek A, Stachowicz K, Szewczyk B, Nowak G, Bojarski A, Kozioł AE, Turło J, Herold F. Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT receptor ligands. European Journal of Medicinal Chemistry. 166: 144-158. PMID 30703658 DOI: 10.1016/J.Ejmech.2019.01.031 |
0.33 |
|
| 2019 |
Zieba A, Kata R, Dudek D, Schlegel-Zawadzka M, Nowak G. Serum trace elements in animal models and human depression: Part III. Magnesium. Relationship with copper. Human Psychopharmacology. 15: 631-635. PMID 12404616 DOI: 10.1002/Hup.231 |
0.389 |
|
| 2019 |
Misztak P, Pańczyszyn-Trzewik P, Nowak G, Sowa-Kucma M. effect of co-administration of zinc and fluoxetine in the chronic restraint stress model of depression in mice European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.844 |
0.375 |
|
| 2019 |
Sowa-Kućma M, Panczyszyn-Trzewik P, Misztak P, Nowak G. Increased oxidative stress in the frontal cortex of suicide victims is associated with changes in NMDA receptor, AMPK activity and magnesium level European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.520 |
0.357 |
|
| 2018 |
Szewczyk B, Szopa A, Serefko A, Poleszak E, Nowak G. The role of magnesium and zinc in depression: similarities and differences. Magnesium Research. 31: 78-89. PMID 30714573 DOI: 10.1684/Mrh.2018.0442 |
0.4 |
|
| 2018 |
Pochwat B, Szewczyk B, Kotarska K, Rafało-Ulińska A, Siwiec M, Sowa JE, Tokarski K, Siwek A, Bouron A, Friedland K, Nowak G. Hyperforin Potentiates Antidepressant-Like Activity of Lanicemine in Mice. Frontiers in Molecular Neuroscience. 11: 456. PMID 30618608 DOI: 10.3389/Fnmol.2018.00456 |
0.415 |
|
| 2018 |
Starowicz G, Jarosz M, Frąckiewicz E, Grzechnik N, Ostachowicz B, Nowak G, Mlyniec K. Long-lasting antidepressant-like activity of the GPR39 zinc receptor agonist TC-G 1008. Journal of Affective Disorders. 245: 325-334. PMID 30419533 DOI: 10.1016/J.Jad.2018.11.003 |
0.447 |
|
| 2018 |
Styczeń K, Sowa-Kućma M, Dudek D, Siwek M, Reczyński W, Szewczyk B, Misztak P, Topór-Mądry R, Opoka W, Nowak G. Zinc and copper concentration do not differentiate bipolar disorder from major depressive disorder. Psychiatria Polska. 52: 449-457. PMID 30218561 DOI: 10.12740/Pp/Onlinefirst/80069 |
0.311 |
|
| 2018 |
Ryszewska-Pokraśniewicz B, Mach A, Skalski M, Januszko P, Wawrzyniak ZM, Poleszak E, Nowak G, Pilc A, Radziwoń-Zaleska M. Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response. Nutrients. 10. PMID 30081500 DOI: 10.3390/Nu10081014 |
0.388 |
|
| 2017 |
Sowa-Kućma M, Styczeń K, Siwek M, Misztak P, Nowak RJ, Dudek D, Rybakowski JK, Nowak G, Maes M. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia. Neurotoxicity Research. PMID 29103192 DOI: 10.1007/S12640-017-9835-5 |
0.363 |
|
| 2017 |
Sowa-Kućma M, Styczeń K, Siwek M, Misztak P, Nowak RJ, Dudek D, Rybakowski JK, Nowak G, Maes M. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28867391 DOI: 10.1016/J.Pnpbp.2017.08.024 |
0.336 |
|
| 2017 |
Kaproń B, Łuszczki J, Paneth A, Wujec M, Siwek A, Karcz T, Mordyl B, Głuch-Lutwin M, Gryboś A, Nowak G, Pająk K, Jóźwiak K, Tomczykowski A, Plech T. Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione - a novel anticonvulsant drug candidate. International Journal of Medical Sciences. 14: 741-749. PMID 28824309 DOI: 10.7150/Ijms.20001 |
0.319 |
|
| 2017 |
Pochwat B, Rafało-Ulińska A, Domin H, Misztak P, Nowak G, Szewczyk B. Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the forced swim test in rats. Neuropharmacology. PMID 28802646 DOI: 10.1016/J.Neuropharm.2017.08.006 |
0.409 |
|
| 2017 |
Popik P, Hołuj M, Kos T, Nowak G, Librowski T, Sałat K. Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents. Neurotoxicity Research. PMID 28577066 DOI: 10.1007/S12640-017-9759-0 |
0.401 |
|
| 2017 |
Satała G, Duszyńska B, Lenda T, Nowak G, Bojarski AJ. Allosteric Inhibition of Serotonin 5-HT7 Receptors by Zinc Ions. Molecular Neurobiology. PMID 28455702 DOI: 10.1007/S12035-017-0536-0 |
0.396 |
|
| 2017 |
Doboszewska U, Wlaź P, Nowak G, Radziwoń-Zaleska M, Cui R, Młyniec K. Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity. Neural Plasticity. 2017: 3682752. PMID 28299207 DOI: 10.1155/2017/3682752 |
0.406 |
|
| 2017 |
Depciuch J, Sowa-Kućma M, Nowak G, Szewczyk B, Doboszewska U, Parlinska-Wojtan M. The role of zinc deficiency-induced changes in the phospholipid-protein balance of blood serum in animal depression model by Raman, FTIR and UV-vis spectroscopy. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 89: 549-558. PMID 28258037 DOI: 10.1016/J.Biopha.2017.01.180 |
0.385 |
|
| 2017 |
Parózyszyn-Trzewik P, Misztak P, Nowak G, Papp M, Gruca P, Sowa-Kucma M. Alterations of Nrf2 nuclear factor are associated with inflammation and oxidative stress in chronic mild stress animal model of depression European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31513-4 |
0.31 |
|
| 2017 |
Bobula B, Hess G, Pańczyszyn-Trzewik P, Misztak P, Sowa-Kucma M, Nowak G, Pilc A, Stachowicz K. The effects of co-administration MTEP antagonist and NS-398 on synaptic plasticity in the frontal cortex and hippocampus of mice European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31416-5 |
0.304 |
|
| 2017 |
Stachowicz K, Sowa-Kucma M, Pańczyszyn-Trzewik P, Misztak P, Nowak G, Pilc A. Chronic co-administration of mGluR5 antagonist (MTEP) with COX-2 inhibitor (NS398) affects DSCAM expression in prefrontal cortex and hippocampus in C57Bl/6J mice European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31407-4 |
0.327 |
|
| 2017 |
Pańczyszyn-Trzewik P, Misztak P, Sowa-Kućma M, Szewczyk B, Nowak G, Pilc A, Stachowicz K. Co-administration of COX-2 inhibitor NS-398 enhances antidepressant effect of mGluR5 antagonist MTEP in mice European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)30077-9 |
0.341 |
|
| 2016 |
Depciuch J, Sowa-Kucma M, Nowak G, Papp M, Gruca P, Misztak P, Parlinska-Wojtan M. Qualitative and quantitative changes in phospholipids and proteins investigated by spectroscopic techniques in animal depression model. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 176: 30-37. PMID 28063309 DOI: 10.1016/J.Saa.2016.12.007 |
0.356 |
|
| 2016 |
Rafalo-Ulinska A, Piotrowska J, Kryczyk A, Opoka W, Sowa-Kucma M, Misztak P, Rajkowska G, Stockmeier CA, Datka W, Nowak G, Szewczyk B. Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims. Journal of Psychiatric Research. 83: 220-229. PMID 27661418 DOI: 10.1016/J.Jpsychires.2016.09.008 |
0.355 |
|
| 2016 |
Siwek M, Sowa-Kućma M, Styczeń K, Misztak P, Nowak RJ, Szewczyk B, Dudek D, Rybakowski JK, Nowak G, Maes M. Associations of Serum Cytokine Receptor Levels with Melancholia, Staging of Illness, Depressive and Manic Phases, and Severity of Depression in Bipolar Disorder. Molecular Neurobiology. PMID 27660275 DOI: 10.1007/S12035-016-0124-8 |
0.381 |
|
| 2016 |
Depciuch J, Sowa-Kućma M, Nowak G, Dudek D, Siwek M, Styczeń K, Parlińska-Wojtan M. Phospholipid-protein balance in affective disorders: Analysis of human blood serum using Raman and FTIR spectroscopy. A pilot study. Journal of Pharmaceutical and Biomedical Analysis. 131: 287-296. PMID 27614042 DOI: 10.1016/J.Jpba.2016.08.037 |
0.329 |
|
| 2016 |
Rafalo A, Zadrozna M, Nowak B, Kotarska K, Wiatrowska K, Pochwat B, Sowa-Kucma M, Misztak P, Nowak G, Szewczyk B. The level of the zinc homeostasis regulating proteins in the brain of rats subjected to olfactory bulbectomy model of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 72: 36-48. PMID 27565434 DOI: 10.1016/J.Pnpbp.2016.08.009 |
0.367 |
|
| 2016 |
Styczeń K, Sowa-Kućma M, Siwek M, Dudek D, Reczyński W, Szewczyk B, Misztak P, Topór-Mądry R, Opoka W, Nowak G. The serum zinc concentration as a potential biological marker in patients with major depressive disorder. Metabolic Brain Disease. PMID 27502410 DOI: 10.1007/S11011-016-9888-9 |
0.379 |
|
| 2016 |
Stefanowicz J, Słowiński T, Wróbel MZ, Herold F, Gomółka AE, Wesołowska A, Jastrzębska-Więsek M, Partyka A, Andres-Mach M, Czuczwar SJ, Łuszczki JJ, Zagaja M, Siwek A, Nowak G, Żołnierek M, et al. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile. Bioorganic & Medicinal Chemistry. PMID 27377863 DOI: 10.1016/J.Bmc.2016.06.038 |
0.352 |
|
| 2016 |
Pochwat B, Nowak G, Szewczyk B. Brain glutamic acid decarboxylase-67kDa alterations induced by magnesium treatment in olfactory bulbectomy and chronic mild stress models in rats. Pharmacological Reports : Pr. 68: 881-885. PMID 27351943 DOI: 10.1016/J.Pharep.2016.04.011 |
0.412 |
|
| 2016 |
Młyniec K, Starowicz G, Gaweł M, Frąckiewicz E, Nowak G. Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist. Journal of Affective Disorders. 201: 179-184. PMID 27235821 DOI: 10.1016/J.Jad.2016.05.007 |
0.463 |
|
| 2016 |
Styczeń K, Sowa-Kućma M, Siwek M, Dudek D, Reczyński W, Misztak P, Szewczyk B, Topór-Mądry R, Opoka W, Nowak G. Study of the Serum Copper Levels in Patients with Major Depressive Disorder. Biological Trace Element Research. PMID 27147437 DOI: 10.1007/S12011-016-0720-5 |
0.354 |
|
| 2016 |
Siwek M, Sowa-Kucma M, Styczen K, Misztak P, Szewczyk B, Topor-Madry R, Nowak G, Dudek D, Rybakowski JK. Thiobarbituric Acid-Reactive Substances: Markers of an Acute Episode and a Late Stage of Bipolar Disorder. Neuropsychobiology. 73: 116-22. PMID 27023678 DOI: 10.1159/000444491 |
0.317 |
|
| 2016 |
Młyniec K, Trojan E, Ślusarczyk J, Głombik K, Basta-Kaim A, Budziszewska B, Skrzeszewski J, Siwek A, Holst B, Nowak G. Immune malfunction in the GPR39 zinc receptor of knockout mice: Its relationship to depressive disorder. Journal of Neuroimmunology. 291: 11-7. PMID 26857489 DOI: 10.1016/J.Jneuroim.2015.12.001 |
0.392 |
|
| 2016 |
Roomruangwong C, Kanchanatawan B, Sirivichayakul S, Mahieu B, Nowak G, Maes M. Lower Serum Zinc and Higher CRP Strongly Predict Prenatal Depression and Physio-somatic Symptoms, Which All Together Predict Postnatal Depressive Symptoms. Molecular Neurobiology. PMID 26846364 DOI: 10.1007/S12035-016-9741-5 |
0.35 |
|
| 2016 |
Satała G, Duszyńska B, Stachowicz K, Rafalo A, Pochwat B, Luckhart C, Albert PR, Daigle M, Tanaka KF, Hen R, Lenda T, Nowak G, Bojarski AJ, Szewczyk B. Concentration-Dependent Dual Mode of Zn Action at Serotonin 5-HT1A Receptors: In Vitro and In Vivo Studies. Molecular Neurobiology. 53: 6869-6881. PMID 26660328 DOI: 10.1007/S12035-015-9586-3 |
0.381 |
|
| 2016 |
Misztak P, Pańczyszyn-Trzewik P, Nowak G, Papp M, Gruca P, Sowa-Kućma M. Chronic mild stress-induced alterations in ΔFosB protein and histone H3 acetylation in the frontal cortex of rats European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31674-1 |
0.301 |
|
| 2016 |
Mlyniec K, Starowicz G, Gawel M, Frackiewicz E, Nowak G. Antidepressant-like properties of the GPR39 (zinc receptor) agonist European Neuropsychopharmacology. 26: S449. DOI: 10.1016/S0924-977X(16)31436-5 |
0.405 |
|
| 2016 |
Pańczyszyn-Trzewik P, Misztak P, Nowak G, Sadlik K, Sowa-Kućma M. Oxidative stress in the brain of suicide victims is associated with alterations in AMPA receptor subunits European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31112-9 |
0.316 |
|
| 2015 |
Styczeń K, Siwek M, Sowa-Kućma M, Dudek D, Reczyński W, Szewczyk B, Misztak P, Topór-Mądry R, Opoka W, Nowak G. The serum magnesium concentration as a potential state marker in patients with unipolar affective disorder. Psychiatria Polska. 49: 1265-1276. PMID 26909401 DOI: 10.12740/Pp/Onlinefirst/44137 |
0.362 |
|
| 2015 |
Depciuch J, Sowa-Kućma M, Misztak P, Szewczyk B, Nowak G, Pankiewicz P, Parlińska-Wojtan M. Olfactory bulbectomy-induced changes in phospholipids and protein profiles in the hippocampus and prefrontal cortex of rats. A preliminary study using a FTIR spectroscopy. Pharmacological Reports : Pr. 68: 521-528. PMID 26891240 DOI: 10.1016/J.Pharep.2015.12.005 |
0.319 |
|
| 2015 |
Doboszewska U, Szewczyk B, Sowa-Kućma M, Noworyta-Sokołowska K, Misztak P, Gołębiowska J, Młyniec K, Ostachowicz B, Krośniak M, Wojtanowska-Krośniak A, Gołembiowska K, Lankosz M, Piekoszewski W, Nowak G. Alterations of Bio-elements, Oxidative, and Inflammatory Status in the Zinc Deficiency Model in Rats. Neurotoxicity Research. PMID 26581375 DOI: 10.1007/S12640-015-9571-7 |
0.369 |
|
| 2015 |
Siwek M, Sowa-Kućma M, Styczeń K, Szewczyk B, Reczyński W, Misztak P, Topór-Mądry R, Nowak G, Dudek D, Rybakowski JK. Decreased serum zinc concentration during depressive episode in patients with bipolar disorder. Journal of Affective Disorders. 190: 272-277. PMID 26540081 DOI: 10.1016/J.Jad.2015.10.026 |
0.369 |
|
| 2015 |
Młyniec K, Nowak G. Up-regulation of the GPR39 Zn(2+)-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient mice. Pharmacological Reports : Pr. 67: 1135-40. PMID 26481532 DOI: 10.1016/J.Pharep.2015.04.003 |
0.467 |
|
| 2015 |
Szewczyk B, Pochwat B, Rafało A, Palucha-Poniewiera A, Domin H, Nowak G. Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc. Neuropharmacology. 99: 517-526. PMID 26297535 DOI: 10.1016/J.Neuropharm.2015.08.026 |
0.42 |
|
| 2015 |
Sałat K, Siwek A, Starowicz G, Librowski T, Nowak G, Drabik U, Gajdosz R, Popik P. Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor. Neuropharmacology. 99: 301-307. PMID 26240948 DOI: 10.1016/J.Neuropharm.2015.07.037 |
0.43 |
|
| 2015 |
Pochwat B, Nowak G, Szewczyk B. Relationship between Zinc (Zn (2+) ) and Glutamate Receptors in the Processes Underlying Neurodegeneration. Neural Plasticity. 2015: 591563. PMID 26106488 DOI: 10.1155/2015/591563 |
0.318 |
|
| 2015 |
Gomółka A, Ciesielska A, Wróbel MZ, Chodkowski A, Kleps J, Dawidowski M, Siwek A, Wolak M, Stachowicz K, Sławińska A, Nowak G, Satała G, Bojarski AJ, Belka M, Ulenberg S, et al. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. Part 5. European Journal of Medicinal Chemistry. 98: 221-36. PMID 26043160 DOI: 10.1016/J.Ejmech.2015.05.003 |
0.319 |
|
| 2015 |
Maes M, Nowak G, Caso JR, Leza JC, Song C, Kubera M, Klein H, Galecki P, Noto C, Glaab E, Balling R, Berk M. Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research. Molecular Neurobiology. PMID 25934103 DOI: 10.1007/S12035-015-9183-5 |
0.34 |
|
| 2015 |
Nowak G. Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action. Pharmacological Reports : Pr. 67: 659-62. PMID 25933983 DOI: 10.1016/J.Pharep.2015.01.015 |
0.421 |
|
| 2015 |
Wolak M, Siwek A, Szewczyk B, Poleszak E, Bystrowska B, Moniczewski A, Rutkowska A, Młyniec K, Nowak G. Evaluation of the role of NMDA receptor function in antidepressant-like activity. A new study with citalopram and fluoxetine in the forced swim test in mice. Pharmacological Reports : Pr. 67: 490-3. PMID 25933959 DOI: 10.1016/J.Pharep.2014.12.003 |
0.478 |
|
| 2015 |
Doboszewska U, Szewczyk B, Sowa-Ku?ma M, M?yniec K, Rafa?o A, Ostachowicz B, Lankosz M, Nowak G. Antidepressant activity of fluoxetine in the zinc deficiency model in rats involves the NMDA receptor complex. Behavioural Brain Research. 287: 323-30. PMID 25845739 DOI: 10.1016/J.Bbr.2015.03.064 |
0.466 |
|
| 2015 |
M?yniec K, Gawe? M, Nowak G. Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists. Behavioural Brain Research. 287: 135-8. PMID 25827929 DOI: 10.1016/J.Bbr.2015.03.053 |
0.485 |
|
| 2015 |
Zajdel P, Bednarski M, Sapa J, Nowak G. Ergotamine and nicergoline - facts and myths. Pharmacological Reports : Pr. 67: 360-3. PMID 25712664 DOI: 10.1016/J.Pharep.2014.10.010 |
0.336 |
|
| 2015 |
M?yniec K, Budziszewska B, Holst B, Ostachowicz B, Nowak G. GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25609596 DOI: 10.1093/Ijnp/Pyu002 |
0.424 |
|
| 2015 |
M?yniec K, Singewald N, Holst B, Nowak G. GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development? Journal of Affective Disorders. 174: 89-100. PMID 25490458 DOI: 10.1016/J.Jad.2014.11.033 |
0.473 |
|
| 2015 |
Doboszewska U, Sowa-Ku?ma M, M?yniec K, Pochwat B, Ho?uj M, Ostachowicz B, Pilc A, Nowak G, Szewczyk B. Zinc deficiency in rats is associated with up-regulation of hippocampal NMDA receptor. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 56: 254-63. PMID 25290638 DOI: 10.1016/J.Pnpbp.2014.09.013 |
0.438 |
|
| 2015 |
Pochwat B, Sowa-Kucma M, Kotarska K, Misztak P, Nowak G, Szewczyk B. Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway. Psychopharmacology. 232: 355-67. PMID 25027582 DOI: 10.1007/S00213-014-3671-6 |
0.433 |
|
| 2015 |
Rafalo A, Kotarska K, Wiatrowska K, Nowak G, Szewczyk B. P.1.h.017 Differential regulation of Zinc Transporters type 1, 3 and 4 in the brain of rats subjected to olfactory bulbectomy model of depression European Neuropsychopharmacology. 25: S290. DOI: 10.1016/S0924-977X(15)30346-1 |
0.333 |
|
| 2015 |
Szewczyk B, Stachowicz K, Nowak G, Daigle M, Luckhart C, Cardin V, Hen R, Tanaka K, Albert P. P.1.b.017 Effects of zinc treatment on the 5-HT1A receptor function: behavioural responses European Neuropsychopharmacology. 25: S187-S188. DOI: 10.1016/S0924-977X(15)30181-4 |
0.341 |
|
| 2015 |
Radziwoń-Zaleska M, Ryszewska-Pokraśniewicz B, Skalski M, Skrzeszewski J, Drozdowicz E, Nowak G, Pilc A, Bałkowiec-Iskra E. Therapeutic drug monitoring of depression – Amplification by magnesium ions Pharmacological Reports. 67: 36. DOI: 10.1016/J.Pharep.2015.06.109 |
0.32 |
|
| 2014 |
Poleszak E, Wo?ko S, Serefko A, Wla? A, Kasperek R, Dudka J, Wróbel A, Nowak G, Wla? P. The effects of ifenprodil on the activity of antidepressant drugs in the forced swim test in mice. Pharmacological Reports : Pr. 66: 1031-6. PMID 25443731 DOI: 10.1016/J.Pharep.2014.06.016 |
0.394 |
|
| 2014 |
Plech T, Kapro? B, Luszczki JJ, Paneth A, Siwek A, Ko?aczkowski M, ?o?nierek M, Nowak G. Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on GABAergic system. European Journal of Medicinal Chemistry. 86: 690-9. PMID 25226229 DOI: 10.1016/J.Ejmech.2014.09.034 |
0.301 |
|
| 2014 |
Sapa J, Zygmunt M, Kulig K, Malawska B, Dudek M, Filipek B, Bednarski M, Kusak A, Nowak G. Evaluation of anticonvulsant activity of novel pyrrolidin-2-one derivatives. Pharmacological Reports : Pr. 66: 708-11. PMID 24948076 DOI: 10.1016/J.Pharep.2014.02.014 |
0.346 |
|
| 2014 |
Szewczyk B, Kotarska K, Daigle M, Misztak P, Sowa-Kucma M, Rafalo A, Curzytek K, Kubera M, Basta-Kaim A, Nowak G, Albert PR. Stress-induced alterations in 5-HT1A receptor transcriptional modulators NUDR and Freud-1. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1763-75. PMID 24946016 DOI: 10.1017/S146114571400100X |
0.357 |
|
| 2014 |
Wośko S, Serefko A, Socała K, Szewczyk B, Wróbel A, Nowak G, Wlaź P, Poleszak E. An anti-immobility effect of spermine in the forced swim test in mice. Pharmacological Reports : Pr. 66: 223-7. PMID 24911073 DOI: 10.1016/J.Pharep.2013.10.002 |
0.433 |
|
| 2014 |
Zygmunt M, Sapa J, Chłoń-Rzepa G, Zagórska A, Siwek A, Pawłowski M, Nowak G. 7-3-Chlorophenypiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione as a serotonin receptor ligands with potential antidepressant activity. Pharmacological Reports : Pr. 66: 505-10. PMID 24905531 DOI: 10.1016/J.Pharep.2013.12.014 |
0.414 |
|
| 2014 |
Pochwat B, Pałucha-Poniewiera A, Szewczyk B, Pilc A, Nowak G. NMDA antagonists under investigation for the treatment of major depressive disorder. Expert Opinion On Investigational Drugs. 23: 1181-92. PMID 24818801 DOI: 10.1517/13543784.2014.918951 |
0.435 |
|
| 2014 |
Nowak G, Pomierny-Chamioło L, Siwek A, Niedzielska E, Pomierny B, Pałucha-Poniewiera A, Pilc A. Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors. Neuropharmacology. 84: 46-51. PMID 24796254 DOI: 10.1016/J.Neuropharm.2014.04.016 |
0.479 |
|
| 2014 |
Młyniec K, Doboszewska U, Szewczyk B, Sowa-Kućma M, Misztak P, Piekoszewski W, Trela F, Ostachowicz B, Nowak G. The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims. Neuropharmacology. 79: 290-7. PMID 24333148 DOI: 10.1016/J.Neuropharm.2013.12.001 |
0.469 |
|
| 2014 |
Pochwat B, Szewczyk B, Sowa-Kucma M, Siwek A, Doboszewska U, Piekoszewski W, Gruca P, Papp M, Nowak G. Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 393-405. PMID 24067405 DOI: 10.1017/S1461145713001089 |
0.493 |
|
| 2014 |
Mlyniec K, Budziszewska B, Skrzeszewski J, Holst B, Nowak G. P.2.a.026 Zinc deficiency versus GPR39-zinc receptor knockout mice in the pathophysiology of depression European Neuropsychopharmacology. 24: S376-S377. DOI: 10.1016/S0924-977X(14)70601-7 |
0.411 |
|
| 2014 |
Doboszewska U, Szewczyk B, Sowa-Kucma M, Mlyniec K, Ostachowicz B, Nowak G. P.1.g.105 Effect of dietary zinc deprivation on expression of NMDA receptor subunits and depressive-like behaviour: a time-course study European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70416-X |
0.428 |
|
| 2013 |
Siwek M, Sowa-Kućma M, Dudek D, Styczeń K, Szewczyk B, Kotarska K, Misztakk P, Pilc A, Wolak M, Nowak G. Oxidative stress markers in affective disorders. Pharmacological Reports : Pr. 65: 1558-71. PMID 24553004 DOI: 10.1016/S1734-1140(13)71517-2 |
0.35 |
|
| 2013 |
Siwek M, Szewczyk B, Dudek D, Styczeń K, Sowa-Kućma M, Młyniec K, Siwek A, Witkowski L, Pochwat B, Nowak G. Zinc as a marker of affective disorders. Pharmacological Reports : Pr. 65: 1512-8. PMID 24552999 DOI: 10.1016/S1734-1140(13)71512-3 |
0.376 |
|
| 2013 |
Wolak M, Siwek A, Szewczyk B, Poleszak E, Pilc A, Popik P, Nowak G. Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test. Pharmacological Reports : Pr. 65: 991-7. PMID 24145093 DOI: 10.1016/S1734-1140(13)71080-6 |
0.464 |
|
| 2013 |
Sowa-Kućma M, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Opoka W, Poleszak E, Pilc A, Nowak G. Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. Journal of Affective Disorders. 151: 924-31. PMID 24055117 DOI: 10.1016/J.Jad.2013.08.009 |
0.476 |
|
| 2013 |
Młyniec K, Budziszewska B, Reczyński W, Doboszewska U, Pilc A, Nowak G. Zinc deficiency alters responsiveness to antidepressant drugs in mice. Pharmacological Reports : Pr. 65: 579-92. PMID 23950580 DOI: 10.1016/S1734-1140(13)71035-1 |
0.364 |
|
| 2013 |
Serefko A, Szopa A, Wlaź P, Nowak G, Radziwoń-Zaleska M, Skalski M, Poleszak E. Magnesium in depression. Pharmacological Reports : Pr. 65: 547-54. PMID 23950577 DOI: 10.1016/S1734-1140(13)71032-6 |
0.374 |
|
| 2013 |
Poleszak E, Wośko S, Serefko A, Szopa A, Wlaź A, Szewczyk B, Nowak G, Wlaź P. Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 46: 29-35. PMID 23774195 DOI: 10.1016/J.Pnpbp.2013.06.001 |
0.451 |
|
| 2013 |
Gabrielsen M, Wołosewicz K, Zawadzka A, Kossakowski J, Nowak G, Wolak M, Stachowicz K, Siwek A, Ravna AW, Kufareva I, Kozerski L, Bednarek E, Sitkowski J, Bocian W, Abagyan R, et al. Synthesis, antidepressant evaluation and docking studies of long-chain alkylnitroquipazines as serotonin transporter inhibitors. Chemical Biology & Drug Design. 81: 695-706. PMID 23574807 DOI: 10.1111/Cbdd.12116 |
0.321 |
|
| 2013 |
Wróbel MZ, Chodkowski A, Herold F, Gomółka A, Kleps J, Mazurek AP, Pluciński F, Mazurek A, Nowak G, Siwek A, Stachowicz K, Sławińska A, Wolak M, Szewczyk B, Satała G, et al. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1. European Journal of Medicinal Chemistry. 63: 484-500. PMID 23524160 DOI: 10.1016/J.Ejmech.2013.02.033 |
0.373 |
|
| 2013 |
MÅ‚yniec K, Nowak G. GPR39 up-regulation after selective antidepressants. Neurochemistry International. 62: 936-9. PMID 23474197 DOI: 10.1016/J.Neuint.2013.02.024 |
0.441 |
|
| 2013 |
Zajdel P, Marciniec K, MaÅ›lankiewicz A, Grychowska K, SataÅ‚a G, DuszyÅ„ska B, Lenda T, Siwek A, Nowak G, Partyka A, Wróbel D, JastrzÄ™bska-WiÄ™sek M, Bojarski AJ, WesoÅ‚owska A, PawÅ‚owski M. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HTâ‚A/5-HTâ‚‚A/5-HT₇ and dopamine Dâ‚‚/D₃ receptors. European Journal of Medicinal Chemistry. 60: 42-50. PMID 23279866 DOI: 10.1016/J.Ejmech.2012.11.042 |
0.319 |
|
| 2013 |
Młyniec K, Budziszewska B, Reczyński W, Sowa-Kućma M, Nowak G. The role of the GPR39 receptor in zinc deficient-animal model of depression. Behavioural Brain Research. 238: 30-5. PMID 23089648 DOI: 10.1016/J.Bbr.2012.10.020 |
0.433 |
|
| 2013 |
Doboszewska U, Szewczyk B, Sowa-Kućma M, Młyniec K, Nowak G. The disruption of CREB/BDNF/TrkB signaling. Dynamic changes induced by zinc deficiency Pharmacological Reports. 65: 119-120. DOI: 10.1016/S1734-1140(13)71432-4 |
0.331 |
|
| 2013 |
Pilc A, Pałucha-Poniewiera A, Brański P, Stachowicz K, Sławińska A, Pomierny-Chamioło L, Nowak G. On the mechanism of antidepressant-like activity of mGlu5 allosteric modulators Pharmacological Reports. 65: 22-23. DOI: 10.1016/S1734-1140(13)71290-8 |
0.318 |
|
| 2013 |
Mlyniec K, Doboszewska U, Budziszewska B, Nowak G. P.2.a.014 The role of the GPR39-Zn2+-sensing receptor in the pathomechanism of depression European Neuropsychopharmacology. 23: S316. DOI: 10.1016/S0924-977X(13)70496-6 |
0.413 |
|
| 2013 |
Doboszewska U, Szewczyk B, Sowa-Kucma M, Mlyniec K, Nowak G. P.1.020 The role of CREB/BDNF/TrkB signalling in the zinc deficiency model of depression European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70022-1 |
0.344 |
|
| 2012 |
Młyniec K, Davies CL, Budziszewska B, Opoka W, Reczyński W, Sowa-Kućma M, Doboszewska U, Pilc A, Nowak G. Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test. Pharmacological Reports : Pr. 64: 567-75. PMID 22814010 DOI: 10.1016/S1734-1140(12)70852-6 |
0.383 |
|
| 2012 |
MÅ‚yniec K, Nowak G. Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants. Pharmacological Reports : Pr. 64: 249-55. PMID 22661173 DOI: 10.1016/S1734-1140(12)70762-4 |
0.377 |
|
| 2012 |
Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology. 20: 127-50. PMID 22271002 DOI: 10.1007/S10787-011-0111-7 |
0.346 |
|
| 2012 |
Szewczyk B, Pałucha-Poniewiera A, Poleszak E, Pilc A, Nowak G. Investigational NMDA receptor modulators for depression. Expert Opinion On Investigational Drugs. 21: 91-102. PMID 22097925 DOI: 10.1517/13543784.2012.638916 |
0.462 |
|
| 2012 |
Lai J, Moxey A, Nowak G, Vashum K, Bailey K, McEvoy M. The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials. Journal of Affective Disorders. 136: e31-9. PMID 21798601 DOI: 10.1016/J.Jad.2011.06.022 |
0.357 |
|
| 2012 |
Pomierny-Chamioło L, Siwek A, Pilc A, Nowak G. Chronic MTEP treatment, like antidepressants, induces adaptive changes in mGlu5 receptors in the rat brain Pharmacological Reports. 64: 490-491. DOI: 10.1016/S1734-1140(12)70824-1 |
0.403 |
|
| 2012 |
Doboszewska U, Szewczyk B, Sowa-Kućma M, Nowak G. Zinc deficiency as a possible model of depression – behavioral evaluation Pharmacological Reports. 64: 488-489. DOI: 10.1016/S1734-1140(12)70821-6 |
0.375 |
|
| 2012 |
Mlyniec K, Budziszewska B, Reczynski W, Nowak G. P.2.b.011 Depression-like symptoms and neurodegeneration under zinc-deficient conditions European Neuropsychopharmacology. 22: S247. DOI: 10.1016/S0924-977X(12)70369-3 |
0.317 |
|
| 2011 |
Wlaź P, Kasperek R, Wlaź A, Szumiło M, Wróbel A, Nowak G, Poleszak E. NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice. Pharmacological Reports : Pr. 63: 1526-32. PMID 22358100 |
0.337 |
|
| 2011 |
Partyka A, Jastrzębska-Więsek M, Szewczyk B, Stachowicz K, Sławińska A, Poleszak E, Doboszewska U, Pilc A, Nowak G. Anxiolytic-like activity of zinc in rodent tests. Pharmacological Reports : Pr. 63: 1050-5. PMID 22001993 DOI: 10.1016/S1734-1140(11)70621-1 |
0.38 |
|
| 2011 |
SÅ‚owiÅ„ski T, Stefanowicz J, Dawidowski M, Kleps J, Czuczwar S, Andres-Mach M, Åuszczki JJ, Nowak G, Stachowicz K, Szewczyk B, SÅ‚awiÅ„ska A, Mazurek AP, Mazurek A, PluciÅ„ski F, Wolska I, et al. Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1. European Journal of Medicinal Chemistry. 46: 4474-88. PMID 21816515 DOI: 10.1016/J.Ejmech.2011.07.022 |
0.316 |
|
| 2011 |
Cieślik K, Sowa-Kućma M, Ossowska G, Legutko B, Wolak M, Opoka W, Nowak G. Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment. Pharmacological Reports : Pr. 63: 537-43. PMID 21602609 DOI: 10.1016/S1734-1140(11)70520-5 |
0.345 |
|
| 2011 |
Poleszak E, Wlaź P, Szewczyk B, Wlaź A, Kasperek R, Wróbel A, Nowak G. A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1535-46. PMID 21461743 DOI: 10.1007/S00702-011-0630-9 |
0.449 |
|
| 2011 |
Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M. (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 659-63. PMID 21376099 DOI: 10.1016/J.Pnpbp.2011.02.019 |
0.316 |
|
| 2011 |
Poleszak E, Socała K, Szopa A, Wróbel A, Szewczyk B, Kasperek R, Blicharska E, Nowak G, Wlaź P. Involvement of NMDA receptor complex in the anxiolytic-like effects of chlordiazepoxide in mice. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 857-64. PMID 21298298 DOI: 10.1007/S00702-011-0585-X |
0.408 |
|
| 2011 |
Sowa-Kućma M, Kowalska M, Szlósarczyk M, Gołembiowska K, Opoka W, Baś B, Pilc A, Nowak G. Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex. Amino Acids. 40: 249-58. PMID 20532950 DOI: 10.1007/S00726-010-0641-0 |
0.393 |
|
| 2011 |
Szewczyk B, Kubera M, Nowak G. The role of zinc in neurodegenerative inflammatory pathways in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 693-701. PMID 20156515 DOI: 10.1016/J.Pnpbp.2010.02.010 |
0.395 |
|
| 2010 |
Opoka W, Sowa-Kućma M, Stachowicz K, Ostachowicz B, Szlósarczyk M, Stypuła A, Młyniec K, Maślanka A, Baś B, Lankosz M, Nowak G. Early lifetime zinc supplementation protects zinc-deficient diet-induced alterations. Pharmacological Reports : Pr. 62: 1211-7. PMID 21273680 DOI: 10.1016/S1734-1140(10)70384-4 |
0.302 |
|
| 2010 |
Nowak B, Zadrożna M, Ossowska G, Sowa-Kućma M, Gruca P, Papp M, Dybała M, Pilc A, Nowak G. Alterations in hippocampal calcium-binding neurons induced by stress models of depression: a preliminary assessment. Pharmacological Reports : Pr. 62: 1204-10. PMID 21273679 DOI: 10.1016/S1734-1140(10)70383-2 |
0.3 |
|
| 2010 |
Pomierny-Chamioło L, Poleszak E, Pilc A, Nowak G. NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice. Pharmacological Reports : Pr. 62: 1186-90. PMID 21273676 DOI: 10.1016/S1734-1140(10)70381-9 |
0.496 |
|
| 2010 |
Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, Zieba A, Pilc A, Popik P, Nowak G. Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. Journal of Affective Disorders. 126: 447-52. PMID 20493532 DOI: 10.1016/J.Jad.2010.04.024 |
0.374 |
|
| 2010 |
Wierońska JM, Brański P, Siwek A, Dybala M, Nowak G, Pilc A. GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus. Brain Research. 1334: 12-24. PMID 20353761 DOI: 10.1016/J.Brainres.2010.03.078 |
0.353 |
|
| 2010 |
Czopek A, Byrtus H, Kołaczkowski M, Pawłowski M, Dybała M, Nowak G, Tatarczyńska E, Wesołowska A, Chojnacka-Wójcik E. Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity. European Journal of Medicinal Chemistry. 45: 1295-303. PMID 20060623 DOI: 10.1016/J.Ejmech.2009.11.053 |
0.372 |
|
| 2010 |
Szewczyk B, Poleszak E, Sowa-Kućma M, Wróbel A, Słotwiński S, Listos J, Wlaź P, Cichy A, Siwek A, Dybała M, Gołembiowska K, Pilc A, Nowak G. The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids. 39: 205-17. PMID 19956994 DOI: 10.1007/S00726-009-0412-Y |
0.471 |
|
| 2010 |
Pomierny-Chamioto L, Siwek A, Piotrowska A, Nowak G. Involvement of the serotonergic and glutamatergic systems in the antidepressant-like activity of MTEP, in the forced swim test in mice Pharmacological Reports. 62: 58-59. DOI: 10.1016/S1734-1140(10)71162-2 |
0.307 |
|
| 2010 |
Poleszak E, Wlaź P, Socała K, Wrobel A, Szewczyk B, Kasperek R, Nowak G. Interaction of glycine/NMDA receptor ligands and antidepressant drugs in the forced swim test Pharmacological Reports. 62: 58. DOI: 10.1016/S1734-1140(10)71161-0 |
0.386 |
|
| 2010 |
Młyniec K, Nowak G. Zinc deficiency-induced pro-depressive behavior in mice. Correlation with corticosterone concentration Pharmacological Reports. 62: 55. DOI: 10.1016/S1734-1140(10)71156-7 |
0.349 |
|
| 2010 |
Nowak G, Sowa-Kućma M, Szewczyk B, Poleszak E, Pilc A. Zinc and magnesium interaction with glutamate system in depression Pharmacological Reports. 62: 23. DOI: 10.1016/S1734-1140(10)71113-0 |
0.376 |
|
| 2010 |
Pilc A, Palucha-Poniewiera A, Wieronska J, Stachowicz K, Branski P, Siwek A, Dybala M, Nowak G. S.28.04 The antidepressant potential of mGluR5 and GABA-B receptor antagonists in rodent models of depression European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70240-6 |
0.396 |
|
| 2009 |
Cichy A, Sowa-Kućma M, Legutko B, Pomierny-Chamioło L, Siwek A, Piotrowska A, Szewczyk B, Poleszak E, Pilc A, Nowak G. Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacological Reports : Pr. 61: 1184-91. PMID 20081255 DOI: 10.1016/S1734-1140(09)70182-3 |
0.47 |
|
| 2009 |
Zagórska A, Jurczyk S, Pawłowski M, Dybała M, Nowak G, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E. Synthesis and preliminary pharmacological evaluation of imidazo[2,1-f]purine-2,4-dione derivatives. European Journal of Medicinal Chemistry. 44: 4288-96. PMID 19679379 DOI: 10.1016/J.Ejmech.2009.07.014 |
0.309 |
|
| 2009 |
Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. Journal of Affective Disorders. 118: 187-95. PMID 19278731 DOI: 10.1016/J.Jad.2009.02.014 |
0.648 |
|
| 2009 |
Papiez MA, Dybala M, Sowa-Kucma M, Krzysciak W, Taha H, Jozkowicz A, Nowak G. Evaluation of oxidative status and depression-like responses in Brown Norway rats with acute myeloid leukemia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 596-604. PMID 19268504 DOI: 10.1016/J.Pnpbp.2009.02.015 |
0.444 |
|
| 2009 |
Szewczyk B, Poleszak E, Wlaź P, Wróbel A, Blicharska E, Cichy A, Dybała M, Siwek A, Pomierny-Chamioło L, Piotrowska A, Brański P, Pilc A, Nowak G. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 323-9. PMID 19150479 DOI: 10.1016/J.Pnpbp.2008.12.011 |
0.412 |
|
| 2009 |
Siwek M, Dudek D, Styczen K, Nowak G. P.2.g.009 Effectiveness of prolonged-release melatonin in chronic insomnia concomitant with depression – naturalistic observation European Neuropsychopharmacology. 19: S476. DOI: 10.1016/S0924-977X(09)70748-5 |
0.341 |
|
| 2008 |
Poleszak E, Szewczyk B, Wlaź A, Fidecka S, Wlaź P, Pilc A, Nowak G. D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacological Reports : Pr. 60: 996-1000. PMID 19211995 |
0.364 |
|
| 2008 |
Szewczyk B, Poleszak E, Sowa-Kućma M, Siwek M, Dudek D, Ryszewska-Pokraśniewicz B, Radziwoń-Zaleska M, Opoka W, Czekaj J, Pilc A, Nowak G. Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacological Reports : Pr. 60: 588-9. PMID 19066406 |
0.315 |
|
| 2008 |
Dybała M, Siwek A, Poleszak E, Pilc A, Nowak G. Lack of NMDA-AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1519-20. PMID 18839056 DOI: 10.1007/S00702-008-0128-2 |
0.431 |
|
| 2008 |
Jarończyk M, Chilmonczyk Z, Mazurek AP, Nowak G, Ravna AW, Kristiansen K, Sylte I. The molecular interactions of buspirone analogues with the serotonin transporter. Bioorganic & Medicinal Chemistry. 16: 9283-94. PMID 18812261 DOI: 10.1016/J.Bmc.2008.09.005 |
0.316 |
|
| 2008 |
Sowa-Kućma M, Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E, Papp M, Pilc A, Nowak G. Antidepressant-like activity of zinc: further behavioral and molecular evidence. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1621-8. PMID 18766297 DOI: 10.1007/S00702-008-0115-7 |
0.43 |
|
| 2008 |
Popik P, Kos T, Sowa-Kućma M, Nowak G. Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology. 198: 421-30. PMID 18458881 DOI: 10.1007/S00213-008-1158-Z |
0.397 |
|
| 2008 |
Brański P, Palucha A, Szewczyk B, Wierońska JM, Pilc A, Nowak G. Antidepressant-like activity of 8-Br-cAMP, a PKA activator, in the forced swim test. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 829-30. PMID 18239846 DOI: 10.1007/S00702-008-0023-X |
0.314 |
|
| 2008 |
Pilc A, Chaki S, Nowak G, Witkin JM. Mood disorders: regulation by metabotropic glutamate receptors. Biochemical Pharmacology. 75: 997-1006. PMID 18164691 DOI: 10.1016/J.Bcp.2007.09.021 |
0.452 |
|
| 2007 |
Poleszak E, Wlaź P, Wróbel A, Dybała M, Sowa M, Fidecka S, Pilc A, Nowak G. Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. Pharmacological Reports : Pr. 59: 595-600. PMID 18048961 |
0.312 |
|
| 2007 |
Stachowicz K, Gołembiowska K, Sowa M, Nowak G, Chojnacka-Wójcik E, Pilc A. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent. Neuropharmacology. 53: 741-8. PMID 17870136 DOI: 10.1016/J.Neuropharm.2007.08.002 |
0.418 |
|
| 2007 |
Poleszak E, Wlaź P, Kedzierska E, Nieoczym D, Wróbel A, Fidecka S, Pilc A, Nowak G. NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacology, Biochemistry, and Behavior. 88: 158-64. PMID 17825400 DOI: 10.1016/J.Pbb.2007.07.018 |
0.406 |
|
| 2006 |
Dybała M, Maciag D, Cichy A, Pomierny-Chamioło L, Partyka A, Librowski T, Nowak G. Medium supplementation with zinc enables detection of imipramine-induced adaptation in glycine/NMDA receptors labeled with [3H]L-689,560. Pharmacological Reports : Pr. 58: 753-7. PMID 17085868 |
0.308 |
|
| 2006 |
Nowak G, Partyka A, Pałucha A, Szewczyk B, Wierońska JM, Dybała M, Metz M, Librowski T, Froestl W, Papp M, Pilc A. Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents. British Journal of Pharmacology. 149: 581-90. PMID 16921399 DOI: 10.1038/Sj.Bjp.0706845 |
0.46 |
|
| 2006 |
Legutko B, Szewczyk B, Pomierny-Chamioło L, Nowak G, Pilc A. Effect of MPEP treatment on brain-derived neurotrophic factor gene expression. Pharmacological Reports : Pr. 58: 427-30. PMID 16845218 |
0.329 |
|
| 2006 |
Szewczyk B, Sowa M, Czupryn A, Wierońska JM, Brański P, Sadlik K, Opoka W, Piekoszewski W, Smiałowska M, Skangiel-Kramska J, Pilc A, Nowak G. Increase in synaptic hippocampal zinc concentration following chronic but not acute zinc treatment in rats. Brain Research. 1090: 69-75. PMID 16674928 DOI: 10.1016/J.Brainres.2006.03.035 |
0.331 |
|
| 2006 |
Popik P, Krawczyk M, Golembiowska K, Nowak G, Janowsky A, Skolnick P, Lippa A, Basile AS. Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677. Cellular and Molecular Neurobiology. 26: 857-73. PMID 16636898 DOI: 10.1007/S10571-006-9012-5 |
0.386 |
|
| 2006 |
Herold F, Król M, Kleps J, Nowak G. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4 European Journal of Medicinal Chemistry. 41: 125-134. PMID 16263195 DOI: 10.1016/J.Ejmech.2005.09.003 |
0.343 |
|
| 2006 |
Siwek M, Dudek D, Datka W, Zieba A, Pilc A, Nowak G. P.2.g.008 Serum zinc level as potential marker in recurrent depressive disorder European Neuropsychopharmacology. 16: S361-S362. DOI: 10.1016/S0924-977X(06)70425-4 |
0.318 |
|
| 2006 |
Siwek M, Dudek D, Datka W, Zieba A, Pilc A, Nowak G. P.2.c.018 Zinc supplementation enhances the therapeutic response in treatment resistant unipolar depression European Neuropsychopharmacology. 16: S322. DOI: 10.1016/S0924-977X(06)70352-2 |
0.343 |
|
| 2005 |
Pilc A, Nowak G. GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. Drugs of Today (Barcelona, Spain : 1998). 41: 755-66. PMID 16395415 DOI: 10.1358/Dot.2005.41.11.904728 |
0.443 |
|
| 2005 |
Siwek M, Wróbel A, Dudek D, Nowak G, Zieba A. [The role of copper and magnesium in the pathogenesis and treatment of affective disorders]. Psychiatria Polska. 39: 911-20. PMID 16358591 |
0.341 |
|
| 2005 |
Poleszak E, Wlaź P, Szewczyk B, Kedzierska E, Wyska E, Librowski T, Szymura-Oleksiak J, Fidecka S, Pilc A, Nowak G. Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice. Pharmacology, Biochemistry, and Behavior. 81: 524-9. PMID 15936065 DOI: 10.1016/J.Pbb.2005.03.017 |
0.35 |
|
| 2004 |
Wróbel A, Nowak G, Ossowska G, Danilczuk Z, Zebrowska-Łupina I, Wielosz M. Effect of chronic treatment with dexamethasone on brain dopamine receptors in mice. Polish Journal of Pharmacology. 56: 399-405. PMID 15520493 |
0.312 |
|
| 2004 |
Klodzinska A, Tatarczyńska E, Chojnacka-Wójcik E, Nowak G, Cosford ND, Pilc A. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. Neuropharmacology. 47: 342-50. PMID 15275823 DOI: 10.1016/J.Neuropharm.2004.04.013 |
0.426 |
|
| 2004 |
Poleszak E, Szewczyk B, Kedzierska E, Wlaź P, Pilc A, Nowak G. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacology, Biochemistry, and Behavior. 78: 7-12. PMID 15159129 DOI: 10.1016/J.Pbb.2004.01.006 |
0.388 |
|
| 2004 |
Nowak G, Legutko B, Szewczyk B, Papp M, Sanak M, Pilc A. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression. European Journal of Pharmacology. 492: 57-9. PMID 15145706 DOI: 10.1016/J.Ejphar.2004.03.038 |
0.328 |
|
| 2004 |
Jurczyk S, Kołaczkowski M, Maryniak E, Zajdel P, Pawłowski M, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E, Bojarski AJ, Charakchieva-Minol S, Duszyńska B, Nowak G, Maciag D. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation. Journal of Medicinal Chemistry. 47: 2659-66. PMID 15115407 DOI: 10.1021/Jm030946U |
0.33 |
|
| 2004 |
Pałucha A, Tatarczyńska E, Brański P, Szewczyk B, Wierońska JM, Kłak K, Chojnacka-Wójcik E, Nowak G, Pilc A. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Neuropharmacology. 46: 151-9. PMID 14680755 DOI: 10.1016/J.Neuropharm.2003.09.006 |
0.411 |
|
| 2004 |
Klodzinska A, Tatarczyńska E, Chojnacka-Wójcik E, Nowak G, Cosford NDP, Pilc A. Corrigendum to “Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor antagonist does not involve GABAA signaling” [Neuropharmacology 47 (2004) 342–350] Neuropharmacology. 47: 1115. DOI: 10.1016/J.Neuropharm.2004.08.006 |
0.379 |
|
| 2003 |
Nowak G, Szewczyk B, Wieronska JM, Branski P, Palucha A, Pilc A, Sadlik K, Piekoszewski W. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Research Bulletin. 61: 159-64. PMID 12832002 DOI: 10.1016/S0361-9230(03)00104-7 |
0.398 |
|
| 2003 |
Ossowska G, Nowak G, Klenk-Majewska B, Danilczuk Z, Zebrowska-Lupina I. Effect of imipramine on brain D-1 and 5-HT-2A receptors in a chronic unpredictable stress model in rats. Polish Journal of Pharmacology. 54: 89-93. PMID 12139115 |
0.303 |
|
| 2002 |
Pilc A, Kłodzińska A, Brański P, Nowak G, Pałucha A, Szewczyk B, Tatarczyńska E, Chojnacka-Wójcik E, Wierońska JM. Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology. 43: 181-7. PMID 12213272 DOI: 10.1016/S0028-3908(02)00082-5 |
0.496 |
|
| 2002 |
Pilc A, Klodzinska A, Nowak G. A role for glutamate in the treatment of anxiety and depression: Focus on group I metabotropic glutamate (mGlu) receptors Drugs of the Future. 27: 753-763. DOI: 10.1358/dof.2002.027.08.687386 |
0.316 |
|
| 2001 |
Kroczka B, Branski P, Palucha A, Pilc A, Nowak G. Antidepressant-like properties of zinc in rodent forced swim test. Brain Research Bulletin. 55: 297-300. PMID 11470330 DOI: 10.1016/S0361-9230(01)00473-7 |
0.378 |
|
| 2001 |
Ossowska G, Nowak G, Kata R, Klenk-Majewska B, Danilczuk Z, Żebrowska-Łupina I. Brain monoamine receptors in a chronic unpredictable stress model in rats. Journal of Neural Transmission. 108: 311-319. PMID 11341483 DOI: 10.1007/S007020170077 |
0.45 |
|
| 2000 |
Nowak G, Kubera M, Maes M. Neuroimmunological aspects of the alterations in zinc homeostasis in the pathophysiology and treatment of depression. Acta Neuropsychiatrica. 12: 49-53. PMID 26976758 DOI: 10.1017/S0924270800035705 |
0.405 |
|
| 2000 |
Ossowska K, Pietraszek M, Wardas J, Nowak G, Zajaczkowski W, Wolfarth S, Pilc A. The role of glutamate receptors in antipsychotic drug action. Amino Acids. 19: 87-94. PMID 11026477 DOI: 10.1007/S007260070037 |
0.403 |
|
| 2000 |
Popik P, Wróbel M, Nowak G. Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. Neuropharmacology. 39: 2278-87. PMID 10974311 DOI: 10.1016/S0028-3908(00)00090-3 |
0.424 |
|
| 2000 |
Schlegel-Zawadzka M, Nowak G. Alterations in serum and brain trace element levels after antidepressant treatment. Part II. Copper. Biological Trace Element Research. 73: 37-45. PMID 10949967 DOI: 10.1385/Bter:73:1:37 |
0.342 |
|
| 2000 |
Nowak G, Li Y, Paul IA. Chronic glycine treatment desensitizes the behavioral response to 1-aminocyclopropanecarboxylic acid (ACPC), a partial agonist at the strychnine-insensitive glycine site of the NMDA receptor complex. Journal of Neural Transmission (Vienna, Austria : 1996). 107: 123-31. PMID 10847554 DOI: 10.1007/S007020050011 |
0.633 |
|
| 2000 |
Harkin A, Nowak G, Paul IA. Corrigendum to: "Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors" European Journal of Pharmacology. 397: 399. PMID 10844140 DOI: 10.1016/S0014-2999(00)00327-7 |
0.619 |
|
| 2000 |
Harkin A, Nowak G, Paul IA. Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors. European Journal of Pharmacology. 389: 187-92. PMID 10688983 DOI: 10.1016/S0014-2999(99)00923-1 |
0.652 |
|
| 2000 |
Ossowska K, Pietraszek M, Wardas J, Nowak G, Walfarth S. CHRONIC NEUROLEPTIC TREATMENT INCREASES THE NUMBER OF CORTICAL NMDA RECEPTORS Behavioural Pharmacology. 11: 346. DOI: 10.1097/00008877-200006000-00050 |
0.408 |
|
| 1999 |
Ossowska K, Pietraszek M, Wardas J, Nowak G, Wolfarth S. Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats Naunyn-Schmiedebergs Archives of Pharmacology. 359: 280-287. PMID 10344526 DOI: 10.1007/Pl00005353 |
0.401 |
|
| 1999 |
Nowak G, Schlegel-Zawadzka M. Alterations in serum and brain trace element levels after antidepressant treatment: part I. Zinc. Biological Trace Element Research. 67: 85-92. PMID 10065601 DOI: 10.1007/Bf02784278 |
0.363 |
|
| 1999 |
Schlegel-Zawadzka M, Zięba A, Dudek D, Krośniak M, Szymaczek M, Nowak G. Serum trace elements in animal models and human depression. Part I. Zinc Human Psychopharmacology-Clinical and Experimental. 14: 83-86. DOI: 10.1002/(Sici)1099-1077(199903)14:2<83::Aid-Hup74>3.0.Co;2-6 |
0.381 |
|
| 1998 |
Nowak G, Legutko B, Skolnick P, Popik P. Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors. European Journal of Pharmacology. 342: 367-70. PMID 9548410 DOI: 10.1016/S0014-2999(97)01589-6 |
0.435 |
|
| 1998 |
Ossowska K, Pietraszek M, Wardas J, Dziedzicka-Wasylewska M, Nowak G, Bajkowska M, Wolfart S. The role of cortical NMDA receptors in the neuroleptic action European Neuropsychopharmacology. 8. DOI: 10.1016/S0924-977X(98)80411-2 |
0.394 |
|
| 1997 |
Zhu H, Paul IA, McNamara M, Redmond A, Nowak G, Piletz JE. Chronic imipramine treatment upregulates IR2-imidazoline receptive sites in rat brain. Neurochemistry International. 30: 101-7. PMID 9116580 DOI: 10.1016/S0197-0186(96)00043-5 |
0.581 |
|
| 1996 |
Nowak G, Li Y, Paul IA. Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment. European Journal of Pharmacology. 295: 75-85. PMID 8925878 DOI: 10.1016/0014-2999(95)00585-4 |
0.64 |
|
| 1996 |
Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry. 29: 23-6. PMID 8852530 DOI: 10.1055/S-2007-979537 |
0.703 |
|
| 1996 |
Nowak G, Papp M, Paul I. The NMDA receptor complex and the action of antidepressant drugs in the CMS model of depression European Journal of Pharmaceutical Sciences. 4: S53. DOI: 10.1016/S0928-0987(97)86204-5 |
0.665 |
|
| 1995 |
Nowak G, Redmond A, McNamara M, Paul IA. Swim stress increases the potency of glycine at the N-methyl-D-aspartate receptor complex. Journal of Neurochemistry. 64: 925-7. PMID 7830087 DOI: 10.1046/J.1471-4159.1995.64020925.X |
0.684 |
|
| 1995 |
Nowak G, Ordway GA, Paul IA. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Research. 675: 157-64. PMID 7796124 DOI: 10.1016/0006-8993(95)00057-W |
0.627 |
|
| 1994 |
Paul IA, Nowak G, Layer RT, Popik P, Skolnick P. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. The Journal of Pharmacology and Experimental Therapeutics. 269: 95-102. PMID 8169857 |
0.645 |
|
| 1993 |
Nowak G, Paul IA, Popik P, Young A, Skolnick P. Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex. European Journal of Pharmacology. 247: 101-2. PMID 8258355 DOI: 10.1016/0922-4106(93)90144-X |
0.684 |
|
| 1993 |
Nowak G, Trullas R, Layer RT, Skolnick P, Paul IA. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. The Journal of Pharmacology and Experimental Therapeutics. 265: 1380-6. PMID 8099620 |
0.65 |
|
| 1993 |
Paul IA, Layer RT, Skolnick P, Nowak G. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. European Journal of Pharmacology. 247: 305-11. PMID 7905831 DOI: 10.1016/0922-4106(93)90199-J |
0.677 |
|
| 1992 |
Nowak G, Zak J. Effect of repeated treatment with antidepressant drugs and electroconvulsive shock (ECS) on the D2 dopaminergic receptor turnover in the rat brain. Pharmacology & Toxicology. 69: 87-9. PMID 1775435 DOI: 10.1111/J.1600-0773.1991.Tb01277.X |
0.399 |
|
| 1992 |
Hyttel J, Nielsen JB, Nowak G. The acute effect of sertindole on brain 5-HT2, D2 and α1 receptors (ex vivo radioreceptor binding studies) Journal of Neural Transmission. 89: 61-69. PMID 1329856 DOI: 10.1007/Bf01245352 |
0.377 |
|
| 1992 |
Paul IA, Trullas R, Skolnick P, Nowak G. Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists. Psychopharmacology. 106: 285-7. PMID 1312732 DOI: 10.1007/Bf02801986 |
0.656 |
|
| 1991 |
Nowak G, Dulinski J. Effect of repeated treatment with electroconvulsive shock (ECS) on serotonin receptor density and turnover in the rat cerebral cortex. Pharmacology, Biochemistry, and Behavior. 38: 691-4. PMID 2068209 DOI: 10.1016/0091-3057(91)90037-3 |
0.389 |
|
| 1991 |
Nowak G, Skolnick P, Paul IA. Down-regulation of dopamine1 (D1) receptors by chronic imipramine is species-specific. Pharmacology, Biochemistry, and Behavior. 39: 769-71. PMID 1838413 DOI: 10.1016/0091-3057(91)90162-U |
0.653 |
|
| 1991 |
Nowak G, Zak J. The turnover of rat cortical alpha 1-adrenoceptors is not modified by repeated electroconvulsive treatment. Journal of Neurochemistry. 56: 2004-6. PMID 1673997 DOI: 10.1111/J.1471-4159.1991.Tb03459.X |
0.308 |
|
| 1990 |
Nowak G, Zak J. Repeated electroconvulsive shock (ECS) enhances striatal D-1 dopamine receptor turnover in rats. European Journal of Pharmacology. 167: 307-8. PMID 2687010 DOI: 10.1016/0014-2999(89)90594-3 |
0.312 |
|
| 1990 |
Klimek V, Nowak G, Żak J, Maj J. The effect of repeated treatment with brofaromine, moclobemide and deprenyl on α1-adrenergic and dopaminergic receptors in the rat brain Neuroscience Letters. 108: 189-194. PMID 2154722 DOI: 10.1016/0304-3940(90)90729-S |
0.386 |
|
| 1988 |
Nowak G, Przegaliński E. Effect of repeated treatment with antidepressant drugs and electroconvulsive shock (ECS) on [3H] prazosin binding to different rat brain structures. Journal of Neural Transmission. 71: 57-64. PMID 2830364 DOI: 10.1007/Bf01259410 |
0.372 |
|
| 1987 |
Pawlowski L, Nowak G. Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: The effects of desipramine, maprotiline, femoxetine and citalopram Journal of Pharmacy and Pharmacology. 39: 1003-1009. PMID 2894425 DOI: 10.1111/J.2042-7158.1987.Tb03148.X |
0.314 |
|
| 1987 |
Maj J, Skuza G, Sowińska H, Nowak G. Pharmacological properties of EXP 561, a potential antidepressant drug Journal of Neural Transmission. 70: 81-97. PMID 2822850 DOI: 10.1007/Bf01252511 |
0.34 |
|
| 1986 |
Maj J, Klimek V, Nowak G. Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex. European Journal of Pharmacology. 119: 113-6. PMID 3002814 DOI: 10.1016/0014-2999(85)90328-0 |
0.33 |
|
| 1985 |
Pawlowski L, Nowak G, Górka Z, Mazela H. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: Effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities Psychopharmacology. 86: 156-163. PMID 3927352 DOI: 10.1007/Bf00431702 |
0.333 |
|
| 1985 |
Przegaliński E, Baran L, Siwanowicz J, Nowak G, Antkiewicz-Michaluk L, Vetulani J. Chronic treatment with the potential antidepressant drug rolipram: the effect on the behavioural responses to adrenergic and dopaminergic receptor agonists with some biochemical correlates Journal of Neural Transmission. 64: 211-226. PMID 3003251 DOI: 10.1007/Bf01256468 |
0.4 |
|
| 1985 |
Mogilnicka E, Klimek V, Nowak G, Czyrak A. Adaptive and differential changes on β- and α2-adrenoreceptors mediated hyperthermia after chronic treatment with antidepressant drugs in the rat kept at high ambient temperature Journal of Neural Transmission. 63: 237-246. PMID 2999329 DOI: 10.1007/Bf01252028 |
0.404 |
|
| 1985 |
Mogilnicka E, Klimek V, Nowak G, Czyrak A. Clonidine and a β-agonists induce hyperthermia in rats at high ambient temperature Journal of Neural Transmission. 63: 223-235. PMID 2999328 DOI: 10.1007/Bf01252027 |
0.307 |
|
| Show low-probability matches. |